SERAFINI MARTA
Publications
Donsante, S., Pievani, A., Palmisano, B., Finamore, M., Fazio, G., Corsi, A., et al. (2024). Modeling skeletal dysplasia in Hurler syndrome using patient-derived bone marrow osteoprogenitor cells. JCI INSIGHT, 9(5) [10.1172/jci.insight.173449]. Detail
Pievani, A., Biondi, M., Tettamanti, S., Biondi, A., Dotti, G., Serafini, M. (2024). CARs are sharpening their weapons. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 12(1) [10.1136/jitc-2023-008275]. Detail
Crespiatico, I., Zaghi, M., Mastini, C., D'Aliberti, D., Mauri, M., Mercado, C., et al. (2024). First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis. BLOOD [10.1182/blood.2023021349]. Detail
Biondi, M., Tettamanti, S., Galimberti, S., Cerina, B., Tomasoni, C., Dotti, G., et al. (2023). Overexpression of CXCR4 receptor on CD33.CAR-CIK cells enhances the control of the Acute Myeloid Leukemia burden. Intervento presentato a: 5th European CAR T-cell meeting, Virtual, online. Detail
Arsuffi, C., Biondi, A., Tettamanti, S., Serafini, M. (2023). Acute Myeloid Leukemia (AML) immunotherapy: development of TIM3-CD33 targeted Dual CAR CIK cells for eradication of LSCs in the bone marrow niche. Intervento presentato a: Giornata Dottorati Medicina, Monza. Detail
Awards
Research and teaching assignments
- Attivita' di insegnamento - Università degli Studi di MILANO-BICOCCA, 2020 - 2021